Skip to content

Obesity and Endogenous Oxalate Synthesis

Obesity and Endogenous Oxalate Synthesis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03808090
Enrollment
58
Registered
2019-01-17
Start date
2013-01-01
Completion date
2024-07-31
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

oxalate, obesity, kidney stones

Brief summary

The goal of this study is to determine if obesity is associated with increased endogenous oxalate synthesis as assessed by urinary oxalate excretion, which is a known risk factor for calcium oxalate kidney stones. The study will recruit adult participants without history of kidney stones. Participants will * Ingest fixed diets containing low amounts of oxalate for 4 days * Collect 24-hr urine samples during the fixed diet

Detailed description

In this study the investigators propose to measure the excretion of urinary oxalate on a fixed diet with controlled amounts of oxalate, in individuals of varying body sizes without history of kidney stones. The 24-hr urinary oxalate excretion on such a low-oxalate normal calcium fixed diet is determined to be an appropriate surrogate for endogenous oxalate synthesis. Screening phase. The study will enroll 60 individuals without history of kidney stones (30 males/30 females) at the University of Alabama at Birmingham (UAB). Screening will include blood complete metabolic profile, 24-hr urine specimens collected at home on self-selected diets and anthropometric measurements. Dietary phase Participants will ingest a low-oxalate (\<60 mg/day), normal calcium (1000 mg/day) fixed diet for 4 consecutive days, collect three 24-hr urines after 1 day of dietary equilibration and have a fasted blood draw on day 5.

Interventions

DIETARY_SUPPLEMENTNormal Individuals

Controlled Dietary phase: Low oxalate fixed diet 4 days of fixed normal calorie diet with low oxalate (\< 60 mg/day), normal calcium (800-1200 mg/day)

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Age 19-70 yrs Body Mass Index \> 18.5 kg/m2 Normal fasting serum electrolytes on comprehensive metabolic profile Willing to ingest fixed diets

Exclusion criteria

Chronic Kidney Disease, estimated glomerular filtration rate \< 60 ml/mn/1.73m2 Primary hyperoxaluria Liver, endocrine or renal diseases or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results, including: Cystic fibrosis, Cystinuria, Uric acid stone former, Nephrotic syndrome, Sarcoidosis, Renal tubular acidosis, Primary hyperparathyroidism, Neurogenic bladder, Urinary diversion Pregnancy or breast-feeding Incompatible dietary requirements with the study, food allergies or intolerance to any of the foods in study menus Active malignancy or treatment for malignancy within 12 months prior to screening Utilization of immunosuppressive medication Uncontrolled Hypertension or diabetes

Design outcomes

Primary

MeasureTime frameDescription
Urinary Oxalate Excretion3 days on the fixed dietMean Urinary oxalate excretion from three 24 hour urine collections on the fixed diet (mg/day)

Secondary

MeasureTime frameDescription
Urinary Glycolate Excretion3 days on fixed dietmean of three 24-hr urinary glycolate collected on the fixed diet (mg/day)
Urinary Creatinine Excretion3 days on the fixed dietmean of there 24hr urinary creatinine excretion on the fixed diet ( g/day)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKyle D Wood, MD

University of Alabama at Birmingham

Participant flow

Recruitment details

total study enrollment

Participants by arm

ArmCount
Normal Individuals
Normal individuals: no prior history of kidney stones Normal Individuals: Controlled Dietary phase: Low oxalate fixed diet 4 days of fixed eucaloric diet with low oxalate (\< 60 mg/day), normal calcium (800-1200 mg/day)
58
Total58

Baseline characteristics

CharacteristicNormal Individuals
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
58 Participants
Age, Continuous38 years
STANDARD_DEVIATION 13
Body Mass Index29 kg/m2
STANDARD_DEVIATION 7
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
52 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
28 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
29 Participants
Region of Enrollment
United States
58 Participants
Sex: Female, Male
Female
35 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 58
other
Total, other adverse events
0 / 58
serious
Total, serious adverse events
0 / 58

Outcome results

Primary

Urinary Oxalate Excretion

Mean Urinary oxalate excretion from three 24 hour urine collections on the fixed diet (mg/day)

Time frame: 3 days on the fixed diet

ArmMeasureValue (MEAN)Dispersion
Normal IndividualsUrinary Oxalate Excretion24 mg/dayStandard Deviation 10
Secondary

Urinary Creatinine Excretion

mean of there 24hr urinary creatinine excretion on the fixed diet ( g/day)

Time frame: 3 days on the fixed diet

ArmMeasureValue (MEAN)Dispersion
Normal IndividualsUrinary Creatinine Excretion1.47 g/dayStandard Error 0.58
Secondary

Urinary Glycolate Excretion

mean of three 24-hr urinary glycolate collected on the fixed diet (mg/day)

Time frame: 3 days on fixed diet

ArmMeasureValue (MEAN)Dispersion
Normal IndividualsUrinary Glycolate Excretion32 mg/dayStandard Deviation 14

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026